(Total Views: 183)
Posted On: 08/26/2024 1:05:42 PM
Post# of 124200
Halberd Corp. (OTC: $HALB) Issues Letter to Shareholders
News Link: https://www.globenewswire.com/en/news-release...lders.html
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to it shareholders:
Halberd Corp. - Taking a Moment to Recenter Our Technical Progress
Introducing Tri-ax TM TBI Nasal Spray Treatment - the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal
This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing concern on how quiet things have been. We agree, but there is a good reason. We attempt to maintain transparency while carefully orchestrating communications to avoid disclosing our secret, proprietary methodologies. Things are changing here at Halberd as we mature our relationship with our key partners. Specifically, as Athena GTX’s CEO, Mark Darrah becomes a full working partner and takes on a full partner’s share of the Strategic Planning and Developments at Halberd, it has taken some time to sort out the best business plans going forward along with competitive, commercialization and legal strategies for Halberd’s evolving products. All together, we are critically focusing on the maximum nearer term returns on each of the technologies that address issues in the world today, putting significant efforts into obtaining government contract money, all the while, assuring we are legally protected with Non-Disclosure Agreements (NDA’s) and intellectual property agreements in place.
This Press Release focuses on the Tri-aX™ TBI nasal spray product evolutions and the recent military interest.
Dr. Darrah recently updated the technical product strategies in cooperation with the Halberd team and in light of the positive pilot programs completed at Mississippi State University under the auspices of Dr. Russell Carr. Knowing this general brain health arena after head trauma is an extremely hot military issue, as well as a commercial interest, Halberd must be cautious about public dissemination of information. It is both a litigious and highly competitive world.
News Link: https://www.globenewswire.com/en/news-release...lders.html
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to it shareholders:
Halberd Corp. - Taking a Moment to Recenter Our Technical Progress
Introducing Tri-ax TM TBI Nasal Spray Treatment - the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal
This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing concern on how quiet things have been. We agree, but there is a good reason. We attempt to maintain transparency while carefully orchestrating communications to avoid disclosing our secret, proprietary methodologies. Things are changing here at Halberd as we mature our relationship with our key partners. Specifically, as Athena GTX’s CEO, Mark Darrah becomes a full working partner and takes on a full partner’s share of the Strategic Planning and Developments at Halberd, it has taken some time to sort out the best business plans going forward along with competitive, commercialization and legal strategies for Halberd’s evolving products. All together, we are critically focusing on the maximum nearer term returns on each of the technologies that address issues in the world today, putting significant efforts into obtaining government contract money, all the while, assuring we are legally protected with Non-Disclosure Agreements (NDA’s) and intellectual property agreements in place.
This Press Release focuses on the Tri-aX™ TBI nasal spray product evolutions and the recent military interest.
Dr. Darrah recently updated the technical product strategies in cooperation with the Halberd team and in light of the positive pilot programs completed at Mississippi State University under the auspices of Dr. Russell Carr. Knowing this general brain health arena after head trauma is an extremely hot military issue, as well as a commercial interest, Halberd must be cautious about public dissemination of information. It is both a litigious and highly competitive world.
(0)
(0)Scroll down for more posts ▼
